Which description best describes 21 CFR Part 210?

Which description best describes 21 CFR Part 210?

• A. Good manufacturing practices for finished pharmaceuticals
• B. Quality and system regulations
• C. Good manufacturing practices for processing and manufacturing
• D. Human subjects protection

Answer: (C)

21 CFR Part 210 defines current good manufacturing practice requirements for drug products during manufacturing, processing, packing, or holding. The description that best matches this scope is good manufacturing practices for processing and manufacturing, because Part 210 focuses on the production and handling steps that directly affect product quality and safety. It isn’t about protecting human subjects (that’s a different regulatory area) and it isn’t specifically about GMP for finished dosage forms (that distinction belongs to Part 211). The term “processing and manufacturing” captures the core activities Part 210 governs, reflecting the emphasis on the production process and related controls to ensure consistent quality.

21 CFR Part 210 defines current good manufacturing practice requirements for drug products during manufacturing, processing, packing, or holding. The description that best matches this scope is good manufacturing practices for processing and manufacturing, because Part 210 focuses on the production and handling steps that directly affect product quality and safety. It isn’t about protecting human subjects (that’s a different regulatory area) and it isn’t specifically about GMP for finished dosage forms (that distinction belongs to Part 211). The term “processing and manufacturing” captures the core activities Part 210 governs, reflecting the emphasis on the production process and related controls to ensure consistent quality.